Literature DB >> 11242455

Immunoregulatory peptides in bovine milk.

H S Gill1, F Doull, K J Rutherfurd, M L Cross.   

Abstract

Bovine milk is known to contain a number of peptide fractions that can affect immune function. The vast majority of immunoregulatory peptides that have been characterised are hydrolysate derivatives of major milk proteins. Recent research has also indicated that the metabolic activity of probiotic lactic acid bacteria can generate de novo immunoregulatory peptides from milk, via enzymatic degradation of parent milk protein molecules. In contrast, relatively little is known of endogenous, preformed immunoregulatory peptides in milk that may be relevant to modulating human health. The natural in vivo role of preformed and enzymatically derived peptides is likely to be one of regulation of the neonatal (bovine) gastrointestinal tract immune system, in order to modulate immune function with respect to the development of immunocompetence and avoidance of undesirable immunological responses (e.g. tolerance, and hypersensitivity to nutrients). There is scope for the further characterisation of both the origin and function of milk-derived immunoregulatory peptides, so that their potential to influence human health can be fully appraised. This review highlights our current knowledge of milk-derived immunoregulatory peptides, and outlines areas that are of relevance for further research.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11242455     DOI: 10.1017/s0007114500002336

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  26 in total

Review 1.  Cheese as Functional Food: The Example of Parmigiano Reggiano and Grana Padano.

Authors:  Andrea Summer; Paolo Formaggioni; Piero Franceschi; Federica Di Frangia; Federico Righi; Massimo Malacarne
Journal:  Food Technol Biotechnol       Date:  2017-09       Impact factor: 3.918

2.  Induction of a humoral immune response following an Escherichia coli O157:H7 infection with an immunomodulatory peptidic fraction derived from Lactobacillus helveticus-fermented milk.

Authors:  Jason Leblanc; Ismail Fliss; Chantal Matar
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

3.  Profile of a milk-allergic patient who tolerated partially hydrolyzed whey formula.

Authors:  Tricia D Lee; Gustavo Gimenez; Galina Grishina; Michelle Mishoe; Hugh A Sampson; Supinda Bunyavanich
Journal:  J Allergy Clin Immunol Pract       Date:  2014-08-29

4.  Evolution of the mammary gland defense system and the ontogeny of the immune system.

Authors:  Armond S Goldman
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-07       Impact factor: 2.673

Review 5.  Growth hormone and prolactin--molecular and functional evolution.

Authors:  Isabel A Forsyth; Michael Wallis
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-07       Impact factor: 2.673

Review 6.  Polymorphism of bovine beta-casein and its potential effect on human health.

Authors:  Stanisław Kamiński; Anna Cieslińska; Elzbieta Kostyra
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

7.  Stimulation of interleukin-10 production by acidic beta-lactoglobulin-derived peptides hydrolyzed with Lactobacillus paracasei NCC2461 peptidases.

Authors:  Guénolée Prioult; Sophie Pecquet; Ismail Fliss
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

8.  Peptidomic profile of milk of Holstein cows at peak lactation.

Authors:  David C Dallas; Andres Guerrero; Evan A Parker; Luis A Garay; Aashish Bhandari; Carlito B Lebrilla; Daniela Barile; J Bruce German
Journal:  J Agric Food Chem       Date:  2013-12-23       Impact factor: 5.279

9.  Modulation of human immune responses by bovine interleukin-10.

Authors:  Gerco den Hartog; Huub F J Savelkoul; Ruud Schoemaker; Edwin Tijhaar; Adrie H Westphal; Talitha de Ruiter; Elise van de Weg-Schrijver; R J Joost van Neerven
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

10.  PGPIPN, a therapeutic hexapeptide, suppressed human ovarian cancer growth by targeting BCL2.

Authors:  Wei Wang; Fang Gu; Cai Wei; Yigui Tang; Xin Zheng; Mingqiang Ren; Yide Qin
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.